Anti-mesothelin CAR-T (Pregene)

Anti-mesothelin CAR-T (普瑞金)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAnti-mesothelin CAR-T (Pregene)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-MesothelinGene transferenceCell replacements
TargetsMesothelin
Therapy Area/IndicationsHydrothorax
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesPregene (Shenzhen) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPregene (Shenzhen) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHydrothorax
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A